{"DataElement":{"publicId":"6347771","version":"1","preferredName":"Sequencing Library Platform Name","preferredDefinition":"The words used to describe the instrument used to carry out a high-throughput sequencing experiment.","longName":"SEQ_LIB_PLATFORM_NM","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"6273336","version":"1","preferredName":"Sequencing Library Platform","preferredDefinition":"A collection of double stranded DNA fragments flanked by oligonucleotide sequence adapters to enable their analysis by high-throughput sequencing._The specific version (manufacturer, model, etc.) of a technology that is used to carry out a laboratory or computational experiment.","longName":"6273321v1.0:2223310v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"6273321","version":"1","preferredName":"Sequencing Library","preferredDefinition":"A collection of double stranded DNA fragments flanked by oligonucleotide sequence adapters to enable their analysis by high-throughput sequencing.","longName":"C148073","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sequencing Library","conceptCode":"C148073","definition":"A collection of double stranded DNA fragments flanked by oligonucleotide sequence adapters to enable their analysis by high-throughput sequencing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6BEC8634-0E48-602E-E053-F662850A059F","latestVersionIndicator":"Yes","beginDate":"2018-05-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-11","modifiedBy":"ONEDATA","dateModified":"2018-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2223310","version":"1","preferredName":"Technology Platform","preferredDefinition":"The specific version (manufacturer, model, etc.) of a technology that is used to carry out a laboratory or computational experiment.","longName":"C45378","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Technology Platform Version","conceptCode":"C45378","definition":"The specific version (manufacturer, model, etc.) of a technology that is used to carry out a laboratory or computational experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B09C1-347C-2590-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"DWARZEL","dateModified":"2023-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435020","version":"1","preferredName":"Diagnostic, Therapeutic, and Research Equipment","preferredDefinition":"An object needed to perform a diagnostic, therapeutic or research activity.","longName":"C19238","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831F-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6BF1CA73-501E-4DFD-E053-F662850A350A","latestVersionIndicator":"Yes","beginDate":"2018-05-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-11","modifiedBy":"KNABLEJ","dateModified":"2018-11-19","changeDescription":"11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.   5/11/18 jk created for MCL Genomics per list provided by WG.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6298110","version":"1","preferredName":"Sequencing Library Platform Name","preferredDefinition":"A collection of double stranded DNA fragments flanked by oligonucleotide sequence adapters to enable their analysis by high-throughput sequencing._The specific version (manufacturer, model, etc.) of a technology that is used to carry out a laboratory or computational experiment._The words or language units by which a thing is known.","longName":"6298110v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Capillary","valueDescription":"AB Capillary","ValueMeaning":{"publicId":"6298104","version":"1","preferredName":"AB Capillary","longName":"6298104v1.00","preferredDefinition":"Capillary sequencing done using an Applied Biosystems capillary sequencing system. Isa: Capillary Sequencing","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Applied Biosystems Capillary Sequencing","conceptCode":"C198570","definition":"Capillary sequencing done using an Applied Biosystems capillary sequencing system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBF1650-4BF6-515D-E053-F662850AE10C","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"COLBERTM","dateModified":"2023-04-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CC01EA9-6F60-2E6F-E053-F662850A4742","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"JKNABLE","dateModified":"2023-05-07","deletedIndicator":"No"},{"value":"ABI Solid","valueDescription":"ABI Solid","ValueMeaning":{"publicId":"6298102","version":"1","preferredName":"ABI Solid","longName":"6298102v1.00","preferredDefinition":"A proprietary next-generation DNA sequencing system from Applied Biosystems that utilizes DNA ligase. DNA fragments attached to beads are clonally amplified and ligated to fluorescently labeled \"interrogation probes\". Ligation frees the fluor, which is detected and identifies the specific probe. The marker of the attached probe is then removed and a 5'-phosphate group is regenerated. Multiple cycles of ligation, detection, and cleavage are performed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"ABI SOLiD Sequencing","conceptCode":"C146811","definition":"A proprietary next-generation DNA sequencing system from Applied Biosystems that utilizes DNA ligase. DNA fragments attached to beads are clonally amplified and ligated to fluorescently labeled \"interrogation probes\". Ligation frees the fluor, which is detected and identifies the specific probe. The marker of the attached probe is then removed and a 5'-phosphate group is regenerated. Multiple cycles of ligation, detection, and cleavage are performed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBF1650-4BB0-515D-E053-F662850AE10C","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"COLBERTM","dateModified":"2023-03-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CC01EA9-6F6B-2E6F-E053-F662850A4742","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"},{"value":"BGISEQ","valueDescription":"BGISEQ","ValueMeaning":{"publicId":"6298101","version":"1","preferredName":"BGISEQ","longName":"6298101v1.00","preferredDefinition":"A proprietary next-generation DNA sequencing system from BGI Genomics using combinatorial Probe-Anchor Synthesis (cPAS) and improved DNA Nanoballs (DNB) technology. The cPAS chemistry works by incorporating a fluorescent probe to a DNA anchor on the DNB, followed by high-resolution digital imaging.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"BGISEQ-500 Sequencing","conceptCode":"C146812","definition":"A proprietary next-generation DNA sequencing system from BGI Genomics using combinatorial Probe-Anchor Synthesis (cPAS) and improved DNA Nanoballs (DNB) technology. The cPAS chemistry works by incorporating a fluorescent probe to a DNA anchor on the DNB, followed by high-resolution digital imaging.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBF1650-4B8D-515D-E053-F662850AE10C","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"COLBERTM","dateModified":"2023-03-31","changeDescription":null,"administrativeNotes":"3/31/23 Added concept C146812. VM previously had no concept. mr","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CC01EA9-6F76-2E6F-E053-F662850A4742","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"},{"value":"Complete Genomics","valueDescription":"Complete Genomics","ValueMeaning":{"publicId":"6298100","version":"1","preferredName":"Complete Genomics","longName":"6298100v1.00","preferredDefinition":"A next-generation DNA sequencing service offered by Complete Genomics. Unamplified human genomic DNA is sheared into 500bp fragments and then amplified to create DNA nano-balls (DNBs). The DNBs are arrayed on a substrate and their sequence is determined by Combinatorial Probe-Anchor Ligation (cPAL) sequencing.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Complete Genomics Sequencing","conceptCode":"C146815","definition":"A next-generation DNA sequencing service offered by Complete Genomics. Unamplified human genomic DNA is sheared into 500bp fragments and then amplified to create DNA nano-balls (DNBs). The DNBs are arrayed on a substrate and their sequence is determined by Combinatorial Probe-Anchor Ligation (cPAL) sequencing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBF1650-4B6A-515D-E053-F662850AE10C","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"COLBERTM","dateModified":"2023-03-31","changeDescription":null,"administrativeNotes":"3/31/23 Added concept. VM previously had none. mr","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CC01EA9-6F81-2E6F-E053-F662850A4742","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"},{"value":"Helicos","valueDescription":"Helicos","ValueMeaning":{"publicId":"6298099","version":"1","preferredName":"Helicos","longName":"6298099v1.00","preferredDefinition":"A proprietary next-generation DNA sequencing system from Helicos BioSciences based on zero wave guide technology and using unamplified DNA templates that are anchored to the surface of a glass slide. For each nucleotide cycle, polymerases are bound to the immobilized templates, and both fluorescently labeled nucleotides and proprietary terminators, which kinetically inhibit the polymerase from incorporating more than a single base, are added. The slide surface is then imaged with a high-intensity laser and where the fluorescent signal detected indicates a base incorporation at that position in the fluorescing template sequence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Helicos Sequencing","conceptCode":"C146816","definition":"A proprietary next-generation DNA sequencing system from Helicos BioSciences based on zero wave guide technology and using unamplified DNA templates that are anchored to the surface of a glass slide. For each nucleotide cycle, polymerases are bound to the immobilized templates, and both fluorescently labeled nucleotides and proprietary terminators, which kinetically inhibit the polymerase from incorporating more than a single base, are added. The slide surface is then imaged with a high-intensity laser and where the fluorescent signal detected indicates a base incorporation at that position in the fluorescing template sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBF1650-4B47-515D-E053-F662850AE10C","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"COLBERTM","dateModified":"2023-05-09","changeDescription":null,"administrativeNotes":"3/31/23 Added concept.  VM previously had none. mr","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CC01EA9-6F8C-2E6F-E053-F662850A4742","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"},{"value":"Illumina","valueDescription":"Illumina","ValueMeaning":{"publicId":"6298098","version":"1","preferredName":"Illumina","longName":"6298098v1.00","preferredDefinition":"A proprietary next-generation DNA sequencing system from Solexa that uses reversible terminator nucleotides. The genomic DNA to be sequenced is fragmented and ligated to adapter molecules on both ends to construct an Illumina-specific adapter library. PCR amplification of the DNA fragments is then performed using the adapter sequence as primer. Sequencing is carried out by repeated cycles of adding reversible fluorescent-labelled nucleotide and incorporation of the nucleotides to the complementary strand. The fluorescence of the incorporated nucleotides is detected.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Illumina Sequencing","conceptCode":"C146817","definition":"A proprietary next-generation DNA sequencing system from Solexa that uses reversible terminator nucleotides. The genomic DNA to be sequenced is fragmented and ligated to adapter molecules on both ends to construct an Illumina-specific adapter library. PCR amplification of the DNA fragments is then performed using the adapter sequence as primer. Sequencing is carried out by repeated cycles of adding reversible fluorescent-labelled nucleotide and incorporation of the nucleotides to the complementary strand. The fluorescence of the incorporated nucleotides is detected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBF1650-4B24-515D-E053-F662850AE10C","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"COLBERTM","dateModified":"2023-03-31","changeDescription":null,"administrativeNotes":"3/31/23 Added concept.  VM previously had none. mr","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CC01EA9-6F97-2E6F-E053-F662850A4742","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"},{"value":"Ion Torrent","valueDescription":"Ion Torrent","ValueMeaning":{"publicId":"6298095","version":"1","preferredName":"Ion Torrent","longName":"6298095v1.00","preferredDefinition":"A method of DNA sequencing based on the detection of hydrogen ions that are released during synthesis of a complementary strand polymerized on a template strand. This technology differs from other sequencing technologies in that no modified nucleotides or optics are used. It claims to be simpler, faster, and more cost effective and scalable than any other technology available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ion Semiconductor Sequencing","conceptCode":"C125894","definition":"A method of DNA sequencing based on the detection of hydrogen ions that are released during synthesis of a complementary strand polymerized on a template strand. This technology differs from other sequencing technologies in that no modified nucleotides or optics are used. It claims to be simpler, faster, and more cost effective and scalable than any other technology available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBF1650-4ABB-515D-E053-F662850AE10C","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"COLBERTM","dateModified":"2023-03-31","changeDescription":null,"administrativeNotes":"3/31/23 Added concept.  VM previously had none. mr","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CC01EA9-6FA2-2E6F-E053-F662850A4742","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"},{"value":"LS 454","valueDescription":"LS 454","ValueMeaning":{"publicId":"6298103","version":"1","preferredName":"LS 454","longName":"6298103v1.00","preferredDefinition":"A proprietary next-generation DNA sequencing system from 454 Life Sciences that used large-scale parallel pyrosequencing. The system relied on fixing nebulized and adapter-ligated DNA fragments to small DNA-capture beads in a water-in-oil emulsion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"454 Sequencing","conceptCode":"C146809","definition":"A proprietary next-generation DNA sequencing system from 454 Life Sciences that used large-scale parallel pyrosequencing. The system relied on fixing nebulized and adapter-ligated DNA fragments to small DNA-capture beads in a water-in-oil emulsion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBF1650-4BD3-515D-E053-F662850AE10C","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"COLBERTM","dateModified":"2023-03-31","changeDescription":null,"administrativeNotes":"3/31/23 Added concept.  VM previously had none. mr","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CC01EA9-6FAD-2E6F-E053-F662850A4742","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"},{"value":"Oxford Nanopore","valueDescription":"Oxford Nanopore","ValueMeaning":{"publicId":"6298097","version":"1","preferredName":"Oxford Nanopore","longName":"6298097v1.00","preferredDefinition":"A proprietary next-generation DNA sequencing technology from Oxford Nanopore Technologies that can directly identify and sequence a DNA molecule as it passes through a nanopore, driven by electrophoresis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nanopore Sequencing","conceptCode":"C146818","definition":"A proprietary next-generation DNA sequencing technology from Oxford Nanopore Technologies that can directly identify and sequence a DNA molecule as it passes through a nanopore, driven by electrophoresis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBF1650-4B01-515D-E053-F662850AE10C","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"COLBERTM","dateModified":"2023-03-31","changeDescription":null,"administrativeNotes":"3/31/23 Added concept.  VM previously had none. mr","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CC01EA9-6FB8-2E6F-E053-F662850A4742","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"},{"value":"PacBio SMRT","valueDescription":"PacBio SMRT","ValueMeaning":{"publicId":"6298096","version":"1","preferredName":"PacBio SMRT","longName":"6298096v1.00","preferredDefinition":"A proprietary third-generation DNA sequencing system from Pacific Biosciences that uses zero-mode waveguides (ZMWs) and phospholinked nucleotides. A single DNA polymerase enzyme is affixed at the bottom of a ZMW structure with a single molecule of DNA as a template. A fluorescent tag is cleaved off with each base addition and is detected to create the sequence.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"SMRT Sequencing","conceptCode":"C146819","definition":"A proprietary third-generation DNA sequencing system from Pacific Biosciences that uses zero-mode waveguides (ZMWs) and phospholinked nucleotides. A single DNA polymerase enzyme is affixed at the bottom of a ZMW structure with a single molecule of DNA as a template. A fluorescent tag is cleaved off with each base addition and is detected to create the sequence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBF1650-4ADE-515D-E053-F662850AE10C","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"COLBERTM","dateModified":"2023-03-31","changeDescription":null,"administrativeNotes":"3/31/23 Added concept.  VM previously had none. mr","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6CC01EA9-6FC3-2E6F-E053-F662850A4742","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","deletedIndicator":"No"},{"value":"Ultima","valueDescription":null,"ValueMeaning":{"publicId":"14728928","version":"1","preferredName":"Ultima Sequencing Platform","longName":"14728928v1.00","preferredDefinition":"A system for whole-genome sequencing that uses a massively parallel sequencing platform that combines an open flow cell design on a circular wafer with a large surface area and mostly natural nucleotides that allow optical end-point detection without reversible terminators. The platform allows for iteratively flowing one nucleotide at a time in order, ensuring that only one nucleotide is responsible for the signal and not requiring the blocking of the other nucleotides, in contrast to traditional technologies that flow all four nucleotides simultaneously.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ultima Sequencing Platform","conceptCode":"C203671","definition":"A system for whole-genome sequencing that uses a massively parallel sequencing platform that combines an open flow cell design on a circular wafer with a large surface area and mostly natural nucleotides that allow optical end-point detection without reversible terminators. The platform allows for iteratively flowing one nucleotide at a time in order, ensuring that only one nucleotide is responsible for the signal and not requiring the blocking of the other nucleotides, in contrast to traditional technologies that flow all four nucleotides simultaneously.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0FC7A7AE-F28F-4600-E063-731AD00AD9FD","latestVersionIndicator":"Yes","beginDate":"2024-01-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2024-01-25","modifiedBy":"COLBERTM","dateModified":"2024-01-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0FC7A7AE-F290-4600-E063-731AD00AD9FD","beginDate":"2024-01-25","endDate":null,"createdBy":"COLBERTM","dateCreated":"2024-01-25","modifiedBy":"COLBERTM","dateModified":"2024-01-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435020","version":"1","preferredName":"Diagnostic, Therapeutic, and Research Equipment","preferredDefinition":"An object needed to perform a diagnostic, therapeutic or research activity.","longName":"C19238","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831F-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6298115","version":"1","preferredName":"Sequencing Library Technology Platform Name","preferredDefinition":"A collection of double stranded DNA fragments flanked by oligonucleotide sequence adapters to enable their analysis by high-throughput sequencing.:The specific version (manufacturer, model, etc.) of a technology that is used to carry out a laboratory or computational experiment.:The words or language units by which a thing is known.","longName":"C148073:C45378:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sequencing Library","conceptCode":"C148073","definition":"A collection of double stranded DNA fragments flanked by oligonucleotide sequence adapters to enable their analysis by high-throughput sequencing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Technology Platform Version","conceptCode":"C45378","definition":"The specific version (manufacturer, model, etc.) of a technology that is used to carry out a laboratory or computational experiment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6CBFDD33-9271-2EB8-E053-F662850A187B","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"ONEDATA","dateModified":"2018-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"6CC01EA9-6F49-2E6F-E053-F662850A4742","latestVersionIndicator":"Yes","beginDate":"2018-05-21","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-05-21","modifiedBy":"COLBERTM","dateModified":"2024-01-25","changeDescription":"11/19/18 jk Added CSI; Released per PI/Maureen at Oct 2018 Steering Comm meeting.   5/15/18 jk created for MCL Genomics sequencing library content.","administrativeNotes":"6/11/23 removed \"other\"; CDS will request new PVs as needed. jk; 5/8/23 Added PV Other per CDS metadata template. mr;\r\n5/7/23 Chg \"Capillary\" PV per SME XLS; removed AB. jk","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"13574489","version":"1","longName":"Childhood Cancer Data Initiative","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"13594223","version":"1","longName":"Sequencing File","context":"Pediatric Cancer"},{"publicId":"13594225","version":"1","longName":"Single Cell Sequencing File","context":"Pediatric Cancer"},{"publicId":"13594094","version":"1","longName":"Sequencing","context":"Pediatric Cancer"}]},{"publicId":"5506117","version":"1","longName":"Genomics","context":"MCL","ClassificationSchemeItems":[{"publicId":"7318222","version":"1","longName":"Candidate Genomic CDEs","context":"MCL"}]},{"publicId":"8064110","version":"1","longName":"CDS (Cancer Data Service)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"12177495","version":"1","longName":"Sequencing","context":"CRDC"}]}],"AlternateNames":[{"name":"CRDC","type":"USED_BY","context":"CRDC"},{"name":"platform","type":"CDS Alt Name","context":"CRDC"},{"name":"platform","type":"CCDI Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"Platform","type":"Preferred Question Text","description":"Platform","url":null,"context":"MCL"},{"name":"CDS","type":"EXAMPLE","description":"Illumina, LS454, PacBio, Ion Torrent","url":null,"context":"CRDC"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"70A7F608-5299-79B5-E053-F662850A3325","latestVersionIndicator":"Yes","beginDate":"2018-07-10","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2018-07-10","modifiedBy":"COLBERTM","dateModified":"2023-11-01","changeDescription":"3/1/22 jk Designated, added CDS alt name and CSI. 10/21/20 jk per SME, moved CDE from Library CSI to Candidate Genomics CSI; not used in current Core. 11/19/18 jk Released per PI/Maureen at Oct 2018 Steering Comm meeting.  7/10/18 jk created for MCL Genomics based on Sequence Read Archive (SRA) data element.","administrativeNotes":"1/19/23 Added CDS ref doc EXAMPLE; removed general CDS CSI, added CDS|Sequencing CSI; per metadata template. mr","unresolvedIssues":null,"deletedIndicator":"No"}}